Chembond Chemicals Ltd
Incorporated in 1974, Chembond Chemicals Ltd manufactures, trades and provides services of Specialty Chemicals[1]
- Market Cap ₹ 338 Cr.
- Current Price ₹ 253
- High / Low ₹ 567 / 229
- Stock P/E 20.8
- Book Value ₹ 117
- Dividend Yield 1.38 %
- ROCE 7.02 %
- ROE 6.29 %
- Face Value ₹ 5.00
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- The company has delivered a poor sales growth of -5.54% over past five years.
- Tax rate seems low
- Company has a low return on equity of 8.74% over last 3 years.
- Earnings include an other income of Rs.9.16 Cr.
- Dividend payout has been low at 8.89% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
274 | 299 | 270 | 291 | 327 | 301 | 268 | 274 | 349 | 440 | 462 | 201 | |
253 | 273 | 259 | 274 | 304 | 275 | 258 | 256 | 332 | 405 | 412 | 188 | |
Operating Profit | 21 | 26 | 11 | 17 | 23 | 26 | 10 | 18 | 17 | 35 | 49 | 14 |
OPM % | 8% | 9% | 4% | 6% | 7% | 8% | 4% | 7% | 5% | 8% | 11% | 7% |
1 | 1 | 189 | 18 | 11 | 4 | 3 | 15 | 9 | 5 | 17 | 9 | |
Interest | 4 | 4 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
Depreciation | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 5 | 6 | 3 |
Profit before tax | 15 | 20 | 195 | 30 | 28 | 24 | 8 | 29 | 21 | 34 | 60 | 19 |
Tax % | 40% | 28% | 20% | 24% | 16% | 19% | 61% | 28% | 32% | 26% | 26% | 10% |
9 | 14 | 156 | 23 | 24 | 20 | 3 | 20 | 14 | 25 | 44 | 18 | |
EPS in Rs | 5.76 | 9.24 | 114.66 | 14.43 | 16.40 | 12.93 | 1.40 | 15.18 | 10.39 | 18.73 | 33.14 | 13.10 |
Dividend Payout % | 26% | 16% | 4% | 11% | 11% | 16% | 144% | 15% | 48% | 16% | 11% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | -4% |
5 Years: | -6% |
3 Years: | -17% |
TTM: | -56% |
Compounded Profit Growth | |
---|---|
10 Years: | 3% |
5 Years: | 55% |
3 Years: | 5% |
TTM: | -59% |
Stock Price CAGR | |
---|---|
10 Years: | 7% |
5 Years: | 19% |
3 Years: | 26% |
1 Year: | -34% |
Return on Equity | |
---|---|
10 Years: | 8% |
5 Years: | 8% |
3 Years: | 9% |
Last Year: | 6% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
Reserves | 80 | 89 | 200 | 223 | 242 | 255 | 262 | 286 | 297 | 315 | 355 | 149 |
33 | 25 | 11 | 9 | 9 | 7 | 3 | 2 | 2 | 7 | 7 | 3 | |
86 | 83 | 72 | 82 | 68 | 54 | 50 | 59 | 56 | 74 | 79 | 43 | |
Total Liabilities | 205 | 203 | 289 | 321 | 325 | 322 | 322 | 354 | 361 | 402 | 447 | 202 |
54 | 51 | 47 | 49 | 108 | 109 | 124 | 122 | 121 | 116 | 122 | 34 | |
CWIP | 3 | 3 | 2 | 2 | 1 | 2 | 0 | 0 | 1 | 12 | 13 | 8 |
Investments | 1 | 1 | 88 | 150 | 76 | 58 | 51 | 73 | 75 | 65 | 92 | 78 |
148 | 147 | 152 | 120 | 140 | 153 | 147 | 160 | 165 | 208 | 220 | 83 | |
Total Assets | 205 | 203 | 289 | 321 | 325 | 322 | 322 | 354 | 361 | 402 | 447 | 202 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
10 | 24 | -27 | 5 | -12 | -12 | 24 | 25 | -10 | 1 | 28 | 19 | |
-6 | -3 | 52 | -0 | 19 | 14 | -12 | -11 | -2 | 1 | -22 | -8 | |
-4 | -18 | -24 | -3 | -4 | -6 | -11 | -2 | -4 | -2 | -5 | -9 | |
Net Cash Flow | -0 | 3 | 1 | 2 | 3 | -5 | 1 | 12 | -16 | 0 | 1 | 2 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 116 | 105 | 78 | 84 | 90 | 110 | 112 | 111 | 94 | 96 | 95 | 72 |
Inventory Days | 74 | 60 | 46 | 59 | 46 | 58 | 77 | 82 | 67 | 53 | 54 | 51 |
Days Payable | 113 | 96 | 86 | 95 | 96 | 84 | 96 | 120 | 76 | 81 | 88 | 103 |
Cash Conversion Cycle | 77 | 70 | 38 | 49 | 40 | 84 | 94 | 73 | 84 | 67 | 62 | 20 |
Working Capital Days | 81 | 69 | 104 | 53 | 53 | 89 | 102 | 85 | 79 | 75 | 70 | 81 |
ROCE % | 15% | 18% | 22% | 12% | 11% | 9% | 3% | 10% | 7% | 10% | 16% | 7% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1 Jun - Submission of Newspaper Advertisement - Audite Financial Results of the Company for the quarter/year ended 31st March, 2025.
-
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
30 May - Approved FY25 audited results, 35% dividend, key director changes, auditor resignation and appointment, ESOP scheme, major corporate restructuring.
-
Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
30 May - Approved audited FY25 results, 35% dividend, major restructuring, key director changes, new auditors, and ESOP scheme.
-
Announcement under Regulation 30 (LODR)-Change in Directorate
30 May - Approved FY25 audited results; Rs1.75 dividend; key director changes; auditor change; ESOP scheme approved.
-
Announcement under Regulation 30 (LODR)-Change in Management
30 May - Audited FY25 results approved; Rs1.75 dividend recommended; new director appointed; CMD re-appointed; auditor changed; ESOP scheme approved.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1][2]
CCL provides specialty chemical solutions, offering metal-treatment chemicals, water-treatment chemicals, and industrial enzymes. Company also manufactures chemicals for the construction and infrastructure sectors, and high-performance coatings for structural protection from corrosion, for floors and walls in clean rooms, and for shop floors and building exteriors. It diversified into equipment-based solutions for water treatment. Additionally, it talso rades in building construction chemicals